Related Experiment Video
Updated: Jun 17, 2025

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
High-affinity agonism at the P2X7 receptor is mediated by three residues outside the orthosteric pocket
Adam C Oken1, Nicolas E Lisi1, Ipsita Krishnamurthy1
1Department of Chemical Physiology & Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.
Abstract:
P2X receptors are trimeric ATP-gated ion channels that activate diverse signaling cascades. Due to its role in apoptotic pathways, selective activation of P2X7 is a potential experimental tool and therapeutic approach in cancer biology. However, mechanisms of high-affinity P2X7 activation have not been defined. We report high-resolution cryo-EM structures of wild-type rat P2X7 bound to the high-affinity agonist BzATP as well as significantly improved apo receptor structures in the presence and absence of sodium. Apo structures define molecular details of pore architecture and reveal how a partially hydrated Na+ ion interacts with the conductance pathway in the closed state. Structural, electrophysiological, and direct binding data of BzATP reveal that three residues just outside the orthosteric ATP-binding site are responsible for its high-affinity agonism. This work provides insights into high-affinity agonism for any P2X receptor and lays the groundwork for development of subtype-specific agonists applicable to cancer therapeutics.
Insights
Researchers uncovered how high-affinity agonists activate P2X7 receptors, crucial for cancer therapy. This study reveals key residues and structural details for developing targeted P2X7 cancer treatments.
Area of Science:
- Molecular Biology
- Structural Biology
- Biophysics
Background:
- P2X receptors are ATP-gated ion channels regulating cellular signaling.
- P2X7 receptor activation is implicated in cancer biology via apoptotic pathways.
- Understanding P2X7 high-affinity activation mechanisms is critical for therapeutic development.
Purpose of the Study:
- To elucidate the structural mechanisms underlying high-affinity activation of the P2X7 receptor.
- To define the molecular details of the P2X7 receptor's pore architecture in its closed state.
- To identify specific residues responsible for high-affinity agonism by BzATP.
Main Methods:
- High-resolution cryo-electron microscopy (cryo-EM) to determine receptor structures.
- Electrophysiological recordings to assess receptor function.
- Direct binding assays to quantify agonist interactions.
Main Results:
- Determined cryo-EM structures of wild-type rat P2X7 with BzATP and apo states.
- Revealed molecular details of pore architecture and Na+ ion interaction in the closed state.
- Identified three specific residues outside the ATP-binding site crucial for BzATP's high-affinity agonism.
Conclusions:
- The study provides atomic-level insights into P2X7 receptor activation by high-affinity agonists.
- Structural and functional data pave the way for developing subtype-specific P2X7 agonists.
- These findings support the potential of P2X7 receptor modulation in cancer therapeutics.
More Related Videos
Related Concept Videos
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
GPCR Desensitization
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

